Medico-pharma nexus: Still alive and kicking


The Medical Council of India (MCI) in February had framed stringent ethical guidelines to demolish the doctor-pharma nexus that undermines the best interests of a patient. Seven months later though, most feel the rules have had little or no deterring effect.

The guidelines mainly elaborate the quantum of punishment for doctors, based on the value of favours or perks received from pharma companies. They state that the doctors found accepting gifts or monetary grants of any kind worth Rs 5,000 to Rs 10,000 would lose registration for three months. The tenure would jump to six months if the value of gifts is more than Rs 10,000 and Rs 50,000. For anything priced up to a lakh, the doctor will lose the licence to practice for one year. “Thanks to the guidelines, the entire unholy affair has only become more clandestine,” said a senior physician with a leading public hospital. He said that at least three surgeons, including one from the public setup, went on an all-expense-paid trip to Europe in August. “The surgeons were asked to make their own travel arrangements, which were reimbursed later. Earlier the bookings were more blatant,” said the doctor, who did not wish to be identified. In an HIV/AIDS conference in Durban that was held in July, a contingent of doctors flew to Australia with their families for a vacation, much before the event was over. Lavish trips to foreign destinations have been the norm for the last couple of years, say industry insiders. A pharma representative told TOI how doctors from metros and even tier II cities outrightly reject Asian destinations. “It has to be an expensive European destination. Of course, the bargaining power of the doctor depends on how many strips of a drug he is capable of selling,” said the representative. It has graduated from buying cars to funding marriages of doctors themselves or their children. For small towns, free medicine samples, lunches, home theatres and car down payments still do the trick. The implant and stent industry is huge, where kickbacks are mostly monetary, said the source who has been in the industry for 17 years.

Dr Abhay Shukla, who co-authored a book highlighting the menace of unwanted tests and procedures, said that the medical councils have to work jointly with the income-tax departments. “The balance sheets of pharma companies ought to have details about the money spent on doctors. That information should be used to prosecute doctors,” he said. He lamented the fact that medical associations as well as councils have done little to address the disturbing issue.

Medical councils, however, say they cannot act till there are actual complaints. “Till the time there are no direct complaints against specific doctors, how can the councils act?” said Dr Shivkumar Utture, former member of the Maharashtra Medical Council. In 2014, the MMC suspended over 50 licences in the state after 400 names came under the scanner for accepting bribes. “All of them have got stay orders from the courts and are back to treating patients,” he said.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati